MAURICE CAIROLI, MD
Medical Oncology Physician in MOORESTOWN, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MAURICE CAIROLI, MD reported a CMS MIPS final score of 88.0742/100 — above the 83.1 national average — and filed 748 Medicare Part D claims in 2023.
- 88.0742/100
- MIPS score · +5 vs avg
- 748
- Part D claims, 2023
- 78%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MAURICE CAIROLI, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
88 Top 44% higher than 56% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
MAURICE CAIROLI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MAURICE CAIROLI, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Jersey
How Medical Oncology Physician compares to other specialties among New Jersey providers
Medical Oncology Physician share within New Jersey
Medical Oncology Physician is one of the more visible NUCC categories in New Jersey
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MAURICE CAIROLI, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 88.0742/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Medical Oncology Physician) — 88.0742/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Medical Oncology Physician US NPIs
88.0742/100 MIPS final score — 5.0 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Medical Oncology Physician. Quality dim: 77.0825.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MAURICE CAIROLI, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 350 YOUNG AVE STE 200, MOORESTOWN, NJ, 08057, with a listed phone of (609) 702-1900. NPI 1124051107 was issued on 07/10/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CAIROLI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 748 prescription claims written by this provider, covering 173 Medicare beneficiaries and totaling roughly $2.0 million in drug spend, split 22% brand-name and 78% generic by claim count, with an opioid prescribing rate of 3.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 88.0742/100 for the 2023 performance year (Quality 77.0825), compared with the national average of 83.1.
Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1124051107 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/10/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MAURICE CAIROLI, MD's current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where MAURICE CAIROLI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MAURICE CAIROLI, MD. Source: openpaymentsdata.cms.gov.
Total received
$14
Largest payer
Genentech USA, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
22% brand-name claims vs 78% generic, on 748 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,470
- Total Day Supply
- 42,381
- Brand vs Generic
- 22% brand / 78% generic
- Brand Drug Cost
- $1.8M
- Generic Drug Cost
- $185K
- Opioid Claims
- 24 (3.2% rate)
Patient Demographics
- Average Patient Age
- 72.9 years
- Avg HCC Risk Score
- 1.51
- Gender Split
- 89% female / 11% male
- Age Distribution
- <65: 17, 65-74: 78, 75-84: 66, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MAURICE CAIROLI, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Letrozole
Letrozole
245 claims
- Anastrozole 94
Anastrozole
94 claims
- Revlimid 42
Revlimid
42 claims
- Exemestane 30
Exemestane
30 claims
- Imatinib Mesylate 30
Imatinib Mesylate
30 claims
- Ibrance 29
Ibrance
29 claims
- Tamoxifen Citrate 28
Tamoxifen Citrate
28 claims
- Oxycodone Hcl 20
Oxycodone Hcl
20 claims
| Drug | Claims |
|---|---|
| Letrozole | 245 |
| Anastrozole | 94 |
| Revlimid Lenalidomide | 42 |
| Exemestane | 30 |
| Imatinib Mesylate | 30 |
| Ibrance Palbociclib | 29 |
| Tamoxifen Citrate | 28 |
| Oxycodone Hcl | 20 |
| Procrit Epoetin Alfa | 19 |
| Venclexta Venetoclax | 17 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How MAURICE CAIROLI, MD fits within the Medical Oncology Physician landscape nationally.
MAURICE CAIROLI, MD's 748 claims are above the specialty average of 689.
Nearby Medical Oncology Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as CAIROLI.
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is MAURICE CAIROLI, MD's specialty? ▼
How much does MAURICE CAIROLI, MD prescribe under Medicare Part D? ▼
What is MAURICE CAIROLI, MD's Medicare quality score? ▼
Where is MAURICE CAIROLI, MD located? ▼
What is MAURICE CAIROLI, MD's NPI number? ▼
Does MAURICE CAIROLI, MD prescribe more brand-name or generic drugs? ▼
Does MAURICE CAIROLI, MD prescribe opioids? ▼
How many Medical Oncology Physician providers are there in the US? ▼
What drugs does MAURICE CAIROLI, MD prescribe most often? ▼
Does MAURICE CAIROLI, MD accept Medicare? ▼
How can I verify MAURICE CAIROLI, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology